NIH-funded research NIH-funded research

Assessing gene editing techniques using mouse models

Official title: Gene Editing and Mouse Models Assessment (GEMMA) Core

Funded at Mc Laughlin Research Institute · NIH-11004619 · Data updated 2026-11-12

The GEMMA Core is here to help scientists in Montana study health and disease using mice by providing them with the tools, training, and support they need to successfully edit genes and manage mouse models.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMc Laughlin Research Institute
NIH-funded
Lab location1 site (Great Falls, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$360,000
NIH project number5P20GM152335-02
Project IDNIH-11004619 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are individuals involved in or affected by conditions that can be studied using mouse models, particularly those related to aggression, anxiety, and other behavioral disorders.

Less likely to help

Patients who do not have conditions that can be modeled in mice or who are not involved in research related to gene editing may not receive direct benefits from this research.

What this research studies

The Gene Editing and Mouse Models Assessment (GEMMA) Core aims to enhance research capabilities by providing essential facilities, expertise, and training for scientists working with mouse models. This initiative supports both COBRE project leaders and other researchers in Montana, offering services such as transgenic and genotyping assistance, mouse colony management, and phenotyping. By fostering a collaborative research environment, GEMMA Core seeks to improve the success rates of projects that explore health and disease mechanisms through innovative gene editing approaches.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment of various health conditions through advanced gene editing techniques.

How similar studies have gone: Previous research has shown success in using similar gene editing approaches in mouse models, indicating a promising avenue for advancing biomedical knowledge.

Where this research is happening

  • Mc Laughlin Research Institute
    Great Falls, United States
    Active

Researchers

  • Principal investigator: Gunn, Teresa M — Mc Laughlin Research Institute
  • Study coordinator: Gunn, Teresa M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.